Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients?

被引：3

作者：

Brouwer M. ^{[1
]}

Gudo P.S. ^{[2
]}

Simbe C.M. ^{[3
]}

Perdigão P. ^{[4
]}

Van Leth F. ^{[5
,6
]}

机构：

[1] Health Alliance International, Technical Assistance Unit, Maputo

[2] Ministry of Health, National TB Programme, Maputo

[3] Ministry of Health, Provincial Health Directorate Manica Province, Chimoio, Maputo

[4] Independent Chest Physician, Maputo

[5] Department of Global Health, Amsterdam Institute for Global Health and Development, University of Amsterdam, 1105 BM, Amsterdam

[6] KNCV Tuberculosis Foundation, The Hague, Postbus 146

来源：

BMC Research Notes | / 6卷 / 1期

关键词：

Africa; HIV; Routine programme data; Tuberculosis;

D O I：

10.1186/1756-0500-6-23

中图分类号：

学科分类号：

摘要：

Background: Antiretroviral therapy (ART) is lifesaving for HIV-infected tuberculosis (TB) patients. ART-use by these patients lag behind compared to HIV-testing and co-trimoxazole preventive therapy. TB programmes provide the data on ART-use by HIV-infected TB patients, however often the HIV services provide the ART. We evaluated whether the data on ART-use in the TB register were complete and correct. The timing of ART initiation was evaluated to assess whether reporting on ART-use could have happened with the TB case finding reporting. We collected data on TB treatment, HIV testing and ART for adult TB cases in 2007 from three TB clinics in Manica Province, Mozambique. These data on use of ART from TB registers were compared with those from the HIV services. Findings. Of 628 patients included, 504 (81%) were tested and of these 356 (71%) were HIV-infected. Of the co-infected patients, 81% registered with the HIV services in the same facility. The TB register was correct on ART-use in 73% of co-infected cases and complete in 74%. Information on ART-use could have been reported with the TB case finding reports in 56% of co-infected patients. Conclusion: The TB register is reasonably correct and complete on ART-use. However, the HIV patient record seems a much better source to provide this information. Reporting on ART-use at the end of the quarter in which TB treatment starts provides the programme with timely but incomplete information. A more complete but less timely picture is available after a year. © 2013 Brouwer et al.; licensee BioMed Central Ltd.

引用

共 14 条

[1]

Global Tuberculosis Control, (2011)

[2]

A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities

[3]

Manual on Use of Routine Data Quality Audit (RDQA) Tool for TB Monitoring, (2009)

[4]

Revised TB Recording and Reporting Forms and Registers - Version 2006

[5]

De Saude M., Tratamento Antiretroviral e Infecções Oportunistas Adulto e Adolescente, (2006)

[6]

Treatment of Tuberculosis: Guidelines for National Programmes

[7]

Grant Performance Assessment Methodology

[8]

Kumwenda M., Tom S., Chan A.K., Mwinjiwa E., Sodhi S., Joshua M., Van Lettow M., Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi, Int J Tuberc Lung Dis, 15, 12, pp. 1663-1668, (2011)

[9]

Rapid Advice Antiretroviral Therapy for HIV Infection in Adults and Adolescents, (2009)

[10]

Njozing N.B., Miguel S.S., Tih P.M., Hurtig A.K., Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon, BMC Public Health, 10, (2010)

← 1 2 →